 Craig Forester
Concepts (179)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hematopoietic Stem Cells | 2 | 2024 | 406 | 0.610 |
Why?
| | Protein Biosynthesis | 5 | 2021 | 433 | 0.540 |
Why?
| | Anemia, Aplastic | 1 | 2015 | 38 | 0.460 |
Why?
| | Cell Differentiation | 2 | 2021 | 1991 | 0.430 |
Why?
| | Bone Marrow | 1 | 2015 | 286 | 0.410 |
Why?
| | Myelodysplastic Syndromes | 1 | 2015 | 135 | 0.410 |
Why?
| | Proteome | 1 | 2018 | 472 | 0.410 |
Why?
| | Cysts | 1 | 2012 | 113 | 0.350 |
Why?
| | cdc25 Phosphatases | 2 | 2007 | 15 | 0.350 |
Why?
| | Proteomics | 1 | 2018 | 1111 | 0.350 |
Why?
| | Skin Diseases | 1 | 2012 | 149 | 0.330 |
Why?
| | Immunosuppressive Agents | 1 | 2015 | 890 | 0.320 |
Why?
| | Mitosis | 2 | 2007 | 192 | 0.320 |
Why?
| | Cerebral Angiography | 1 | 2009 | 109 | 0.310 |
Why?
| | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2009 | 80 | 0.290 |
Why?
| | Protein Phosphatase 2 | 2 | 2007 | 41 | 0.290 |
Why?
| | CDC2 Protein Kinase | 1 | 2007 | 31 | 0.280 |
Why?
| | Lung Diseases | 1 | 2012 | 767 | 0.240 |
Why?
| | Signal Transduction | 2 | 2018 | 5079 | 0.230 |
Why?
| | Anemia, Diamond-Blackfan | 1 | 2024 | 1 | 0.230 |
Why?
| | GATA1 Transcription Factor | 1 | 2024 | 18 | 0.230 |
Why?
| | TOR Serine-Threonine Kinases | 2 | 2018 | 412 | 0.230 |
Why?
| | Brain Neoplasms | 2 | 2015 | 1238 | 0.230 |
Why?
| | Liver Neoplasms | 2 | 2019 | 786 | 0.200 |
Why?
| | Genetic Therapy | 1 | 2024 | 297 | 0.200 |
Why?
| | Haploinsufficiency | 1 | 2021 | 56 | 0.180 |
Why?
| | Ribosomal Proteins | 1 | 2021 | 93 | 0.170 |
Why?
| | Extremities | 1 | 2021 | 131 | 0.170 |
Why?
| | Pseudouridine | 1 | 2019 | 4 | 0.160 |
Why?
| | Anemia, Macrocytic | 1 | 2019 | 4 | 0.160 |
Why?
| | Eye Abnormalities | 1 | 2019 | 13 | 0.160 |
Why?
| | RNA, Ribosomal, 18S | 1 | 2019 | 26 | 0.160 |
Why?
| | RNA, Small Nuclear | 1 | 2019 | 37 | 0.160 |
Why?
| | Genes, Tumor Suppressor | 1 | 2019 | 86 | 0.160 |
Why?
| | Endopeptidases | 1 | 2019 | 90 | 0.150 |
Why?
| | Tomography, X-Ray Computed | 1 | 2009 | 2691 | 0.150 |
Why?
| | Diagnosis, Differential | 2 | 2015 | 1483 | 0.150 |
Why?
| | Magnetic Resonance Imaging | 2 | 2019 | 3566 | 0.150 |
Why?
| | Kell Blood-Group System | 1 | 2018 | 1 | 0.150 |
Why?
| | alpha-Thalassemia | 1 | 2018 | 4 | 0.150 |
Why?
| | Craniofacial Abnormalities | 1 | 2019 | 72 | 0.150 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2019 | 92 | 0.150 |
Why?
| | Rh-Hr Blood-Group System | 1 | 2018 | 12 | 0.150 |
Why?
| | Protein Processing, Post-Translational | 1 | 2021 | 465 | 0.150 |
Why?
| | ras Proteins | 1 | 2019 | 153 | 0.150 |
Why?
| | Puromycin | 1 | 2018 | 10 | 0.150 |
Why?
| | beta-Thalassemia | 1 | 2018 | 36 | 0.140 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2021 | 430 | 0.140 |
Why?
| | Eukaryotic Initiation Factor-2 | 1 | 2018 | 29 | 0.140 |
Why?
| | Isoantibodies | 1 | 2018 | 60 | 0.140 |
Why?
| | K562 Cells | 1 | 2018 | 89 | 0.140 |
Why?
| | Ganglia, Spinal | 1 | 2018 | 77 | 0.140 |
Why?
| | Sciatic Nerve | 1 | 2018 | 58 | 0.140 |
Why?
| | Carcinogenesis | 1 | 2019 | 217 | 0.140 |
Why?
| | Cell Cycle Proteins | 1 | 2021 | 617 | 0.140 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2021 | 528 | 0.130 |
Why?
| | Drug Discovery | 1 | 2018 | 142 | 0.130 |
Why?
| | Erythrocyte Transfusion | 1 | 2018 | 194 | 0.130 |
Why?
| | Axons | 1 | 2018 | 198 | 0.130 |
Why?
| | Chromatography, Liquid | 1 | 2018 | 433 | 0.120 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2019 | 362 | 0.120 |
Why?
| | Survival Analysis | 2 | 2019 | 1325 | 0.120 |
Why?
| | Thioridazine | 1 | 2015 | 1 | 0.120 |
Why?
| | Ether-A-Go-Go Potassium Channels | 1 | 2015 | 6 | 0.120 |
Why?
| | Tandem Mass Spectrometry | 1 | 2018 | 532 | 0.110 |
Why?
| | Clonal Evolution | 1 | 2015 | 45 | 0.110 |
Why?
| | RNA | 1 | 2021 | 921 | 0.110 |
Why?
| | Medical Records | 1 | 2015 | 177 | 0.110 |
Why?
| | Immunotherapy | 1 | 2019 | 641 | 0.110 |
Why?
| | Drug Delivery Systems | 1 | 2015 | 365 | 0.090 |
Why?
| | Mice | 7 | 2024 | 17787 | 0.090 |
Why?
| | Evolution, Molecular | 1 | 2015 | 493 | 0.090 |
Why?
| | Radiography, Thoracic | 1 | 2012 | 167 | 0.090 |
Why?
| | Up-Regulation | 2 | 2019 | 843 | 0.090 |
Why?
| | Prostatic Neoplasms | 1 | 2018 | 1043 | 0.080 |
Why?
| | Humans | 14 | 2024 | 137585 | 0.080 |
Why?
| | Predictive Value of Tests | 1 | 2015 | 2031 | 0.080 |
Why?
| | Intracranial Hemorrhages | 1 | 2009 | 85 | 0.080 |
Why?
| | Animals | 9 | 2024 | 36940 | 0.080 |
Why?
| | Osteosarcoma | 1 | 2009 | 74 | 0.080 |
Why?
| | Ribosomes | 2 | 2021 | 186 | 0.080 |
Why?
| | Enzyme Activation | 2 | 2007 | 810 | 0.080 |
Why?
| | Mutation | 1 | 2019 | 3958 | 0.070 |
Why?
| | Cerebellar Neoplasms | 1 | 2009 | 152 | 0.070 |
Why?
| | Cerebellum | 1 | 2009 | 224 | 0.070 |
Why?
| | Bone Neoplasms | 1 | 2009 | 247 | 0.070 |
Why?
| | 14-3-3 Proteins | 1 | 2006 | 18 | 0.070 |
Why?
| | Xenopus Proteins | 1 | 2006 | 37 | 0.070 |
Why?
| | Xenopus | 1 | 2006 | 87 | 0.070 |
Why?
| | Phosphoprotein Phosphatases | 1 | 2006 | 67 | 0.060 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2007 | 283 | 0.060 |
Why?
| | Neoplasms | 1 | 2021 | 2671 | 0.060 |
Why?
| | Surveys and Questionnaires | 1 | 2018 | 5778 | 0.060 |
Why?
| | Infant, Newborn | 2 | 2019 | 6079 | 0.060 |
Why?
| | Lentivirus | 1 | 2024 | 56 | 0.060 |
Why?
| | Male | 7 | 2019 | 67762 | 0.060 |
Why?
| | Erythropoiesis | 1 | 2024 | 55 | 0.060 |
Why?
| | Genetic Vectors | 1 | 2024 | 319 | 0.050 |
Why?
| | Female | 6 | 2019 | 73304 | 0.050 |
Why?
| | Cell Line | 1 | 2007 | 2847 | 0.050 |
Why?
| | Phenotype | 2 | 2021 | 3196 | 0.050 |
Why?
| | Protein Binding | 1 | 2007 | 2224 | 0.040 |
Why?
| | RNA Editing | 1 | 2021 | 24 | 0.040 |
Why?
| | Body Patterning | 1 | 2021 | 132 | 0.040 |
Why?
| | Treatment Outcome | 1 | 2015 | 10811 | 0.040 |
Why?
| | Eukaryotic Initiation Factor-4E | 1 | 2019 | 27 | 0.040 |
Why?
| | 5' Untranslated Regions | 1 | 2019 | 58 | 0.040 |
Why?
| | Immune Evasion | 1 | 2019 | 58 | 0.040 |
Why?
| | Rats, Inbred BB | 1 | 2018 | 6 | 0.040 |
Why?
| | Open Reading Frames | 1 | 2019 | 123 | 0.040 |
Why?
| | Structure-Activity Relationship | 1 | 2019 | 570 | 0.040 |
Why?
| | Cell Size | 1 | 2018 | 91 | 0.040 |
Why?
| | Unfolded Protein Response | 1 | 2018 | 59 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2019 | 139 | 0.030 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 267 | 0.030 |
Why?
| | Genetic Association Studies | 1 | 2019 | 377 | 0.030 |
Why?
| | Mice, Inbred Strains | 1 | 2018 | 409 | 0.030 |
Why?
| | 3' Untranslated Regions | 1 | 2018 | 145 | 0.030 |
Why?
| | Mutation, Missense | 1 | 2019 | 341 | 0.030 |
Why?
| | Retrospective Studies | 1 | 2015 | 15657 | 0.030 |
Why?
| | B7-H1 Antigen | 1 | 2019 | 217 | 0.030 |
Why?
| | Kaplan-Meier Estimate | 1 | 2019 | 889 | 0.030 |
Why?
| | Down-Regulation | 1 | 2019 | 657 | 0.030 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2021 | 860 | 0.030 |
Why?
| | Alleles | 1 | 2019 | 891 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2019 | 658 | 0.030 |
Why?
| | Phosphoproteins | 1 | 2018 | 338 | 0.030 |
Why?
| | Imaging, Three-Dimensional | 1 | 2019 | 580 | 0.030 |
Why?
| | Pyrimidines | 1 | 2019 | 470 | 0.030 |
Why?
| | COS Cells | 1 | 2015 | 188 | 0.030 |
Why?
| | Gene Expression Regulation | 1 | 2024 | 2607 | 0.030 |
Why?
| | Pyridines | 1 | 2019 | 506 | 0.030 |
Why?
| | Base Sequence | 1 | 2019 | 2181 | 0.030 |
Why?
| | Child | 1 | 2015 | 21935 | 0.030 |
Why?
| | Tumor Microenvironment | 1 | 2019 | 674 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2021 | 3015 | 0.030 |
Why?
| | Drosophila | 1 | 2015 | 154 | 0.030 |
Why?
| | Genotype | 1 | 2019 | 1916 | 0.030 |
Why?
| | Models, Molecular | 1 | 2019 | 1570 | 0.030 |
Why?
| | RNA-Binding Proteins | 1 | 2018 | 422 | 0.030 |
Why?
| | Mice, Nude | 1 | 2015 | 698 | 0.030 |
Why?
| | Tumor Cells, Cultured | 1 | 2015 | 955 | 0.030 |
Why?
| | Adolescent | 2 | 2009 | 21513 | 0.030 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2019 | 1396 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2015 | 1272 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2018 | 2486 | 0.020 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2015 | 872 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 2019 | 1457 | 0.020 |
Why?
| | Models, Biological | 1 | 2019 | 1783 | 0.020 |
Why?
| | Disease Progression | 1 | 2019 | 2757 | 0.020 |
Why?
| | Young Adult | 2 | 2019 | 13209 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2019 | 2426 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2015 | 2167 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2018 | 2833 | 0.020 |
Why?
| | Rats | 1 | 2018 | 5647 | 0.020 |
Why?
| | Fatal Outcome | 1 | 2009 | 303 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2019 | 4295 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2019 | 5757 | 0.020 |
Why?
| | Biomarkers | 1 | 2019 | 4149 | 0.020 |
Why?
| | Femur | 1 | 2009 | 254 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2019 | 7635 | 0.020 |
Why?
| | Phosphothreonine | 1 | 2006 | 6 | 0.020 |
Why?
| | Interphase | 1 | 2006 | 32 | 0.020 |
Why?
| | Intermediate Filaments | 1 | 2006 | 28 | 0.020 |
Why?
| | Holoenzymes | 1 | 2006 | 24 | 0.020 |
Why?
| | Checkpoint Kinase 1 | 1 | 2006 | 30 | 0.020 |
Why?
| | HCT116 Cells | 1 | 2006 | 80 | 0.020 |
Why?
| | Antineoplastic Agents | 1 | 2018 | 2129 | 0.020 |
Why?
| | Keratins | 1 | 2006 | 173 | 0.020 |
Why?
| | Adult | 2 | 2019 | 37929 | 0.020 |
Why?
| | Protein Subunits | 1 | 2006 | 239 | 0.020 |
Why?
| | Infant | 1 | 2019 | 9465 | 0.010 |
Why?
| | HeLa Cells | 1 | 2006 | 636 | 0.010 |
Why?
| | DNA Replication | 1 | 2006 | 238 | 0.010 |
Why?
| | Protein Kinases | 1 | 2006 | 319 | 0.010 |
Why?
| | Phosphorylation | 1 | 2006 | 1759 | 0.010 |
Why?
| | United States | 1 | 2018 | 14841 | 0.010 |
Why?
| | Aged | 1 | 2019 | 23961 | 0.010 |
Why?
| | Middle Aged | 1 | 2019 | 33479 | 0.010 |
Why?
|
|
Forester's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|